Advertisement

Topics

News about Biotechnology, Pharmaceutical and Healthcare

21:42 EST 16th January 2017 | BioPortfolio

Latest news articles in the life-science, healthcare, medical device, biotechnology and pharmaceuticals sectors. 

Showing News Articles 1–25 of 30,000+

Monday 16th January 2017

Stimulant boosts function in patients recovering from depression – Daily Mail

Stimulant boosts function in patients recovering from depressionDaily MailLONDON, Jan 17 (Reuters) - People recovering from depression but struggling with its effect on memory, concentration and cognitive function may benefit from the stimulant modafinil, according to results of a small study published on Tuesday. Modafinil ...Patients recovering from depression show improvements in memory from th...

UK midwife shortage leaves women feeling ‘like cattle’, report finds – The Guardian

The GuardianUK midwife shortage leaves women feeling 'like cattle', report findsThe GuardianThe report found 17% of women did not get continuous one-to-one care from midwives. Photograph: David Jones/PA. Hannah Summers. Monday 16 January 2017 19.01 EST Last modified on Monday 16 January 2017 19.02 EST. Share on Facebook · Share ...Midwives crisis alarm as half of women giving birth suffer 'red fl...

Colic study stirs prickly debate on acupuncture – CNN

CNNColic study stirs prickly debate on acupunctureCNN(CNN) The shrill sobs just won't stop. Although some bawling is normal for babies, excessive crying for more than three hours a day, lasting more than three days a week, might be a sign that a doctor's intervention is in order. Excessive crying is ...Acupuncture helps young babies stop crying - new researchTelegraph.co.ukThis two-week treatment ...

Pregnant women can boost their child’s IQ by up to a year’s schooling by taking supplements – Mirror.co.uk

Mirror.co.ukPregnant women can boost their child's IQ by up to a year's schooling by taking supplementsMirror.co.ukWomen taking certain vitamins during pregnancy can boost their child's IQ by up to a year's schooling, a study suggests. Children of mums who had taken multiple micronutrient supplements had “measurably greater” cognitive ability, researchers found.Mums-to-be who take 2p-a-day pre...

Acupuncture helps young babies stop crying – new research – Telegraph.co.uk

Telegraph.co.ukAcupuncture helps young babies stop crying - new researchTelegraph.co.ukAcupuncture can have a potent effect in persuading babies to stop crying, new research has found. Doctors practised the ancient Chinese needle technique on a batch of babies who were crying for more than three hours a day and found they came through ...Will colicky babies benefit from acupuncture?Yahoo Newsall 3...

Failing to take multivitamins during pregnancy could set child back a year in school, study suggests – Telegraph.co.uk

Telegraph.co.ukFailing to take multivitamins during pregnancy could set child back a year in school, study suggestsTelegraph.co.ukFailing to take multivitamins during pregnancy could set a child back by a year by the time they reach secondary school, a new study suggests. The issue of taking supplements is controversial for pregnant women, with research last year suggesting that ...Pregnant women ...

Sales of tampons tumble as women shun menstrual cycle in favour of contraceptives that stop bleeding – The Sun

The SunSales of tampons tumble as women shun menstrual cycle in favour of contraceptives that stop bleedingThe SunSALES of tampons have tumbled over the past four years as women increasingly opt for contraceptives that stop periods. According to researchers at Kantar Worldpanel, the amount spent on the sanitary products fell by almost a quarter from £56m to £43m.End to periods? Tampon sa...

Bird flu confirmed at Lincolnshire turkey farm – BT.com

BT.comBird flu confirmed at Lincolnshire turkey farmBT.comBird flu has been confirmed in a flock of about 6,000 turkeys at a farm in Lincolnshire, the Department for Environment, Food and Rural Affairs (Defra) has said. 0. Share this. Facebook; Twitter; Google plus; Email; Share. 0. Defra has confirmed that ...Confirmed case of avian flu on Lincolnshire farmITV NewsUganda confirms Avian flu in wil...

More than 7000 nurses could face axe under secret NHS plans – Telegraph.co.uk

Telegraph.co.ukMore than 7000 nurses could face axe under secret NHS plansTelegraph.co.ukMore than 7,000 nurse posts could be axed from NHS hospitals across the country despite a mounting Accident & Emergency crisis, new plans reveal. Every area has been ordered to draw up meaures to save £22bn and reorganise health services in order to ...STPs could cost £15m in management consultan...

Carton of lemons offers simple lesson about breast cancer – CNN

CNNCarton of lemons offers simple lesson about breast cancerCNNActor Ben Stiller revealed in October he was diagnosed with prostate cancer in 2014. The tumor was surgically removed three months later, in September 2014, and Stiller has been cancer-free since. Hide Caption. 2 of 36. In August 2015, actress Shannen ...Signs of breast cancer explained, using lemonsBBC NewsHow this picture of lemons i...

New NICE ultra-rare disease proposals "not fit for purpose", says BIA

The BioIndustry Association (BIA) has accused new proposals put forward by the National Institute for Health and Care Excellence (NICE) of being “not fit for purpose” and potentially denying patients from accessing treatments for ultra-rare disease. read more

Preconception care: dietary and lifestyle advice

Engagement by women with a pharmacist or healthcare professional for preconception advice and care ranges between 18% and 45%. Pharmacists are uniquely placed to provide this advice when individuals present for new registration checks, well-woman consultations, contraceptive advice and reviews, as well as medicine use reviews.

Chi-Med Presents Phase I/II Clinical Data for Selective VEGFR Inhibitor Fruquintinib at the 2017 Gastrointestinal Cancers Symposium

Monday, January 16th 2017 at 8:54am UTC LONDON–(BUSINESS WIRE)– Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that data from the ongoing Phase I/II clinical trial of fruquintinib in combination with paclitaxel (Taxol®) in second-line patients with advanced gastric cancer will be presented at the 2017 Gastrointestinal Cancers Symposium sponsored by ...

Chi-Med Initiates a Phase II Combination Study of Fruquintinib with Iressa® (gefitinib) in First-Line Non-Small Cell Lung Cancer

Monday, January 16th 2017 at 8:47am UTC LONDON–(BUSINESS WIRE)– Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that it has initiated a Phase II study of a combination therapy using fruquintinib and Iressa® in the first-line setting for patients with advanced or metastatic non-small cell lung cancer (“NSCLC”) in China. Fruquintinib is a highly &#...

10x Genomics Announces Publication of Study in Nature Communications Demonstrating Single Cell Profiling in Leukemia Patients by the Fred Hutchinson Cancer Research Center

Monday, January 16th 2017 at 11:00am UTC – Study of data from patients with acute myeloid leukemia uses Company’s single-cell RNA-sequencing technology to yield the most comprehensive single cell data sets to date – PLEASANTON, Calif.–(BUSINESS WIRE)– 10x Genomics, Inc., a company focused on enabling the mastery of biology by accelerating genomic discovery, today announce...

The Future Five: Innovations We Might See in 2017 or in the Very Near Future

Monday, January 16th 2017 at 3:03pm UTC –(BUSINESS WIRE)– Just a few years ago, minimally invasive surgery to treat serious conditions such as stroke and heart valve defects was unimaginable. But technology has brought us to the point where such patients can be treated quickly and safely through intravenous microsurgery, often walking around within hours … Cet article The Future ...

Chi-Med Initiates a Phase II Study of Sulfatinib in Second-line Biliary Tract Cancer in China

Monday, January 16th 2017 at 8:52am UTC LONDON–(BUSINESS WIRE)– Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that it has initiated a Phase II study of sulfatinib in second-line biliary tract cancer (“BTC”) patients in China. Sulfatinib is an oral, novel angio-immunokinase inhibitor that selectively targets vascular endothelial growth factor rec...

Rho, Inc. Implements Phlexglobal’s PhlexEview 4 as Transformative eTMF Solution.

Monday, January 16th 2017 at 12:10pm UTC AMERSHAM, England & MALVERN, Pa.–(BUSINESS WIRE)– Phlexglobal, pioneers in the specialist provision of electronic Trial Master File (eTMF) technology and TMF services to the life sciences industry, is thrilled to announce that Chapel Hill, North Carolina-based CRO Rho, Inc. (Rho) has implemented PhlexEview4 as its chosen eTMF solution. ̷...

Helius Medical Technologies Announces Launch of Sixth Site for Pivotal Mild to Moderate Traumatic Brain Injury Clinical Trial

Monday, January 16th 2017 at 2:00pm UTC NEWTOWN, Pa.–(BUSINESS WIRE)– Helius Medical Technologies, Inc. (TSX: HSM, OTCQB: HSDT) (« Helius » or the « Company ») is pleased to announce that MedStar National Rehabilitation Hospital in Washington D.C., has been launched as the sixth site to provide services supporting Helius’ ongoing pivotal trial...

MPs urge government to set out plans for post-Brexit medicines regulation

MPs have urged the government to set out its plans for regulatory functions currently delivered by the EU, including those relating to medicines safety, as soon as possible.

Two legal cases against pharmacy cuts to be heard jointly in March 2017

The UK High Court will consider two legal actions against the government’s decision to cut community pharmacy funding in a hearing set for March 2017.

Biogen’s Spinraza Significantly Reduces Risk of Death or Permanent Ventilation in Infantile-Onset SMA

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Biogen presented new data from the Phase 3 ENDEAR study of SPINRAZA™ (nusinersen), which demonstrated a statistically significant reduction in the risk of death or permanent ventilation in SPINRAZA-treated infants with spinal muscular atrophy (SMA) compared to untreated infants. The data were presented at the British Paediatric Neurology Association (...

FDA Grants Redhill Biopharma’s Treatment for Nontuberculous Mycobacteria Infections QIDP Fast Track Designation

RHB-104 has been granted Qualified Infectious Disease Product (QIDP) designation by the U.S. FDA for the treatment of Nontuberculous Mycobacteria (NTM) Infection Under FDA’s Generating Antibiotic Incentives Now (GAIN) Act, QIDP designation allows for Fast-Track status and Priority Review, potentially leading to a shorter NDA review time by the FDA, and, if approved, an additional …

Inappropriate piece about increasing OTC sales

I am concerned about one of your recent articles, particularly the headline ‘How pharmacists can boost sales of over-the-counter (OTC) medicines’ (Pharmaceutical Journal online, 9 January 2016).

BIOQuébec et Biotech Finances créent un partenariat

BIOQuébec et Biotech Finances unissent leurs forces pour faire connaître les entreprises en sciences de la vie du Québec à travers la francophonie tout en faisant découvrir à nos entreprises d’ici, le portrait d’autres organisations francophones de leur industrie à travers le monde.   « Nous sommes ravis d’étendre la toile de l’information en sciences de la … Cet article ...


Quick Search
Advertisement